B. Fauroux (Paris, France), N. Regamey (Bern, Switzerland)
Ciliary beat frequency in nasal and bronchial epithelial cells in patients with cystic fibrosis
S. Alikadic, F. Horak, T. Frischer, E. Nachbaur, S. Renner, S. Gruber (Vienna, Austria)
|   |
Molecular structure, packing and release of MUC2 with relevance to cystic fibrosis
H. Nilsson, D. Ambort, G. Hansson, H. Hebert (Huddinge, Gothenburg, Sweden)
| |
TGFβ1 genotype in correlation to TGFβ1 induced sputum (IS) and serum in cystic fibrosis (CF)
S. Schmitt-Grohé, F. Schreiner, L. van den Boom, D. N‘Gampolo, O. Eickmeier, R. Schubert, I. Broeckart, S. Zielen, M. Lentze (Bonn, Frankfurt, Germany)
| |
Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis
B. Fauroux, S. Adnot, P. R. Burgel, J. L. Pepin, P. Y. Boelle, C. Cracowski, M. Murris-Espin, R. Nove-Josserand, N. Stremler, T. Simon, T. Damy (Paris, Creteil, Grenoble, Toulouse, Lyon, Marseille, France)
| |
Non invasive ventilation for advanced cystic fibrosis lung disease in children
E. Chan, J. Panickar, B. Thomas (Manchester, United Kingdom)
| |
Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis
J. Widger, M. Oliver, F. Cameron, S. Ranganathan, P. Robinson (Melbourne, Australia)
| |
Pre-procedure antibiotics and effect on microbiological yield from broncho-alveolar lavage fluid in children with cystic fibrosis
S. Kansra, A. Smyth, C. Bertenshaw, A. Ward, M. Hurley, J. Bhatt (Nottingham, United Kingdom)
| |
Inspiratory and expiratory reactance at 5Hz in adult cystic fibrosis
K. Hurt, P. Paredi, H. Kalsi, M. Hodson, D. Bilton, O. Usmani (London, United Kingdom)
| |
Lung clearance index (LCI) at age 1-4 years vs lung function and chest X-ray (CXR) scores at age 7 years in children with CF
A. Lindblad, F. Aljassim, P. Gustafsson (Gothenburg, Skövde, Sweden)
| |
Combination of inhaled corticosteroids and long acting beta two agonists improve lung clearance index (LCI) in preschoolers with cystic fibrosis
E. Hatziagorou, V. Avramidou, S. Botskariova, F. Kirvassilis, J. Tsanakas (Thessaloniki, Greece)
| |
Respiratory muscle strength (RMS) in cystic fibrosis adult patients
N. Marcal, J. Pimentel, S. Moreira, M. Alves, J. Valenca, R. Staats, M. Aguiar, P. Cardim, C. Lopes, A. Bugalho de Almeida (Lisbon, Portugal)
| |
Frequent detection of rhinovirus in bronchoalveolar lavage samples from children with cystic fibrosis
E. Kieninger, C. Tapparel, M. N. Kronig, F. Singer, P. Latzin, H. L. Tan, C. Bossley, C. Casaulta, A. Bush, J. C. Davies, L. Kaiser, N. Regamey (Bern, Geneva, Switzerland; London, United Kingdom)
| |
Whooping cough in cystic fibrosis (CF)
M. Murris, N. Guiso, E. Njamkepo, L. Tetu, A. Didier (Toulouse, Paris, France)
| |
Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF)
A. Adams, R. Thursfield, A. Bush (London, United Kingdom)
| |
Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis
E. Vanderhelst, L. De Meirleir, S. Verbanck, D. Piérard, W. Vincken, A. Malfroot (Brussels, Belgium)
| |
Prevalence and reservoirs of A. xylosoxidans and S. maltophilia in cystic fibrosis center
I. Asherova, S. Monachova, M. Ershova, S. Angelova (Yaroslavl, Russian Federation)
| |
Quality of life of paediatric patients with cystic fibrosis and their caregivers
R. Bodnar, K. Holics, R. Ujhelyi, L. Kovacs, A. Meszaros, L. Kadar (Budapest, Torokbalint, Hungary)
| |